stockrowIllumina, Inc. (ILMN) vs Medpace Holdings, Inc. (MEDP)
- Illumina, Inc. ILMN 209.82 −7.38%
- Medpace Holdings, Inc. MEDP 634.63 −3.37%
Illumina, Inc. and Medpace Holdings, Inc. are both Diagnostics & Research companies. Illumina, Inc. is the larger, with a market value of $31.5B against $17.8B — 1.8× the size. Medpace Holdings, Inc. trades at the lower P/E: 34.6× against 35.6×. Medpace Holdings, Inc. grew revenue faster over the last twelve months: 20.4% against 5.83%. Illumina, Inc. has the higher net margin (19.7% vs 18.2%) and the higher return on invested capital (16.7% vs 0.00%). Across the 22 metrics below, Medpace Holdings, Inc. leads on 16 and Illumina, Inc. on 6.
Valuation
Profitability
| Metric | ILMN | MEDP | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 67.87% | 72.24% | 48.32% |
| Operating margin | 21.18% | 21.39% | (5.68%) |
| Net margin | 19.72% | 18.24% | (4.10%) |
| Free cash flow margin | 23.29% | 23.52% | 0.00% |
| Return on equity | 32.39% | 117.88% | 0.00% |
| Return on assets | 13.78% | 25.54% | (6.05%) |
| Return on invested capital | 16.70% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack